Star Health and Allied Insurance Company Limited (STARHEALTH) Revenue 2023–2026

Name: Star Health and Allied Insurance Company Limited (STARHEALTH) revenue history 2023-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Star Health and Allied Insurance Company Limited annual revenue for fiscal 2026 was ₹181.5 billion, an increase of 10.1% from ₹164.9 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

STARHEALTH Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹181.5B	₹164.9B	₹144.1B	₹122.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STARHEALTH Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹52.9B	₹46.5B	₹45.7B	₹46.9B	₹40.8B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

1299 Revenue — AIA Group Limited
ICICIPRULI Revenue — ICICI Prudential Life Insurance Company Limited
0945 Revenue — Manulife Financial Corporation
MFSL Revenue — Max Financial Services Limited
2601 Revenue — China Pacific Insurance (Group) Co., Ltd.
2378 Revenue — Prudential plc

More STARHEALTH metrics: Net Income · EPS · Free Cash Flow

All STARHEALTH financial statements → Interactive STARHEALTH charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.